missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Gibco™ Leibovitz's L-15 Medium, powder
Leibovitz's L-15 Medium, powder
Brand: Gibco™ 41300021
This item is not returnable.
View return policy
Description
Leibovitz's L-15 Medium supports the growth of HEP-2 monkey kidney cells and primary explants of embryonic and adult human tissue. L-15 is buffered by phosphates and free base amino acids instead of sodium bicarbonate. This medium is designed for supporting cell growth in environments without CO2 equilibration.Product Intended Use
For in vitro diagnostic use. CAUTION: Not for human or animal therapeutic use. Uses other than the intended use may be a violation of local law.
cGMP Manufacturing and Quality System
Gibco™ L-15 is manufactured at a cGMP compliant facility, located in Paisley, Scotland, UK. The facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standard. For supply chain continuity, we offer a comparable Gibco™ L-15 product made in our Grand Island facility (41300-039). This facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standards.
L-15 contains no proteins, lipids, or growth factors. Therefore, L-15 requires supplementation, commonly with 10% Fetal Bovine Serum (FBS).
Powder forms of Gibco™ L-15 cell culture medium require pH adjustment and filtration at the time of preparation (see protocol for details).
Specifications
ISO 13485 standards, FDA | |
Leibovitz's L-15 Medium, 1L, Powder, 7.7 to 8.1 pH, With Galactose, Phenol Red, L-glutamine, Sodium Pyruvate, 36 Months Shelf Life, 290 to 330mOsm/kg Osmolality, For Mammalian Cell Culture | |
Leibovitz's L-15 Medium | |
No Glucose, No HEPES, No Sodium Bicarbonate | |
7.7 to 8.1 |
2 to 8°C | |
Powder | |
Glutamine, Galactose, Phenol Red, Sodium Pyruvate | |
Mammalian cell culture | |
1 L |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction